MedTrace Logo

Radicle ClarityTM 25_SR.1: A Study Assessing the Impact of Health and Wellness Products on Cognitive Function

NCT07013630 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2025-11-03

No results posted yet for this study

Summary

A randomized, double-blind, placebo-controlled direct-to-consumer study assessing the impact of health and wellness products on cognitive function and related health outcomes

Conditions

  • Cognitive Function

Interventions

DIETARY_SUPPLEMENT

Clarity Placebo Control

Participants will use their Clarity Placebo Control as directed for a period of 6 weeks.

DIETARY_SUPPLEMENT

Clarity Active Product

Participants will use their Clarity Active Product as directed for a period of 6 weeks.

Sponsors & Collaborators

  • Radicle Science

    lead INDUSTRY

Principal Investigators

  • Susan Hewlings · Radicle Science Inc.

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
105 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-06-26
Primary Completion
2025-10-03
Completion
2025-10-03

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07013630 on ClinicalTrials.gov